Cargando…
IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175448/ https://www.ncbi.nlm.nih.gov/pubmed/32321563 http://dx.doi.org/10.1186/s13054-020-02878-7 |
| _version_ | 1783524834467119104 |
|---|---|
| author | Dufranc, Etienne Del Bello, Arnaud Belliere, Julie Kamar, Nassim Faguer, Stanislas |
| author_facet | Dufranc, Etienne Del Bello, Arnaud Belliere, Julie Kamar, Nassim Faguer, Stanislas |
| author_sort | Dufranc, Etienne |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7175448 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71754482020-04-22 IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome Dufranc, Etienne Del Bello, Arnaud Belliere, Julie Kamar, Nassim Faguer, Stanislas Crit Care Research Letter BioMed Central 2020-04-22 /pmc/articles/PMC7175448/ /pubmed/32321563 http://dx.doi.org/10.1186/s13054-020-02878-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Research Letter Dufranc, Etienne Del Bello, Arnaud Belliere, Julie Kamar, Nassim Faguer, Stanislas IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome |
| title | IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome |
| title_full | IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome |
| title_fullStr | IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome |
| title_full_unstemmed | IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome |
| title_short | IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome |
| title_sort | il6-r blocking with tocilizumab in critically ill patients with hemophagocytic syndrome |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175448/ https://www.ncbi.nlm.nih.gov/pubmed/32321563 http://dx.doi.org/10.1186/s13054-020-02878-7 |
| work_keys_str_mv | AT dufrancetienne il6rblockingwithtocilizumabincriticallyillpatientswithhemophagocyticsyndrome AT delbelloarnaud il6rblockingwithtocilizumabincriticallyillpatientswithhemophagocyticsyndrome AT bellierejulie il6rblockingwithtocilizumabincriticallyillpatientswithhemophagocyticsyndrome AT kamarnassim il6rblockingwithtocilizumabincriticallyillpatientswithhemophagocyticsyndrome AT faguerstanislas il6rblockingwithtocilizumabincriticallyillpatientswithhemophagocyticsyndrome AT il6rblockingwithtocilizumabincriticallyillpatientswithhemophagocyticsyndrome |